| Literature DB >> 23568610 |
Tristan de Rond1, Pamela Peralta-Yahya, Xiaoliang Cheng, Trent R Northen, Jay D Keasling.
Abstract
Mass spectrometry based technologies are promising as generalizable high-throughput assays for enzymatic activity. In one such technology, a specialized enzyme substrate probe is presented to a biological mixture potentially exhibiting enzymatic activity, followed by an in situ enrichment step using fluorous interactions and nanostructure-initiator mass spectrometry. This technology, known as Nimzyme, shows great potential but is limited by the need to synthesize custom substrate analogs. We describe a synthetic route that simplifies the production of these probes by fashioning their perfluorinated invariant portion as an alkylating agent. This way, a wide variety of compounds can be effectively transformed into enzyme activity probes. As a proof of principle, a chloramphenicol analog synthesized according to this methodology was used to detect chloramphenicol acetyltransferase activity in cell lysate. This verifies the validity of the synthetic strategy employed and constitutes the first reported application of Nimzyme to a non-carbohydrate-active enzyme. The simplified synthetic approach presented here may help advance the application of mass spectrometry to high-throughput enzyme activity determination.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23568610 PMCID: PMC3637890 DOI: 10.1007/s00216-013-6888-z
Source DB: PubMed Journal: Anal Bioanal Chem ISSN: 1618-2642 Impact factor: 4.142
Fig. 1Overview of the Nimzyme technology. a Performing protein purification on a large number of samples is usually prohibitive. Hence, high-throughput activity assays are typically performed in whole cells or in cell lysate, which requires separation by chromatography before mass spectrometric analysis. b Workflow of the high-throughput Nimzyme enzyme activity assay as described in ref. [2]. Enzyme substrate analogs harboring perfluoroalkyl moieties are incubated in a complex mixture exhibiting enzymatic activity (e.g., crude cell lysate). The mixture is quenched and spotted (e.g., using acoustic deposition) on a NIMS chip coated with a perfluorinated initiator substance. The surface is subjected to aqueous washes, allowing cell debris to be rinsed away while fluorous interactions with the chip surface retain the analytes. Subsequent NIMS, performed on a MALDI-TOF mass spectrometer, generates mass spectra where the ratio of substrate to product mass speaks is a measure of enzyme activity. c Generalized anatomy of a Nimzyme substrate. Substrate analogs that can be employed in Nimzyme require a perfluorinated moiety to allow for in situ cleanup and an ionizable group to improve NIMS sensitivity. d The retrosynthetic strategy employed in this manuscript. The invariable part of these substrates is synthesized once, in the form of tosylate alkylating agents 1 and 2. These can react with a wide variety of nucleophiles to provide Nimzyme-amenable substrate analogs. Key: Ts = p-toluenesulfonyl; Pbf = 2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl
Fig. 2Convenient synthesis of Nimzyme probes and their suitability for the detection of CAT activity in cell lysate. a Synthesis of Nimzyme substrates using tosylates 1 and 2 as alkylating agents, and NIMS spectra of the products purified only by F-SPE (for 1), or liquid–liquid extraction (for 2). Yields reported are combined yields for alkylation, purification, and (for 1) deprotection. b CAT catalyzes the O -acetylation of chloramphenicol. c Chloramphenicol analog 11 was synthesized through the alkylation of (1R,2R)-2-amino-1-(4-nitrophenyl)-1,3-propanediol with 1 according to the methodology shown. d Exposure of 11 to control lysate followed by the Nimzyme workflow shown in Fig. 1b shows a clean mass peak corresponding to 11 (expected M+H, m/z = 896.26). e Exposure of 11 to lysate of E. coli having expressed CAT, followed by Nimzyme, shows a mass shift of exactly one acetyl unit relative to 11 (expected M+H, m/z = 938.26). Key: THF = tetrahydrofuran; TFA = trifluoroacetic acid; DMF = N,N′-dimethylformamide